SI-BONE
$28.489876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$28.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.29 (-1.01%) Today
$0.00 (0.00%) As of 9:57 PM UTC after-hours
Why Robinhood?
You can buy or sell SI-BONE and other stocks, options, and ETFs commission-free!
About SIBN
SI-BONE, Inc. Common Stock, also called SI-BONE, is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm’s product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA. The listed name for SIBN is SI-BONE, Inc. Common Stock.
CEO
Jeffrey W. Dunn
Employees
262
Headquarters
Santa Clara, California
Founded
2008
Market Cap
942.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
313.48K
High Today
$29.25
Low Today
$27.93
Open Price
$28.53
Volume
333.48K
52 Week High
$32.00
52 Week Low
$7.20
Collections
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
SIBN Earnings
-$0.64
-$0.43
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 8, After Hours